肾上腺素市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003412
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 144
Buy Now

[研究报告]2018年肾上腺素市场价值为224787万美元,预计到2027年将达到420788万美元;预计2019年至2027年复合年增长率为8.3%。

肾上腺素是一种与紧急医疗服务一起使用的药物,用于治疗由昆虫引起的过敏反应咬伤或蜇伤、食物、药物和乳胶等。它的作用是放松气道肌肉并收紧血管。该注射剂可作为预装自动注射装置提供,其中包含溶液并装在小瓶中以进行皮下注射和其他注射。通常在出现严重过敏反应的第一个迹象时按需要注射注射剂。肾上腺素市场的增长归因于过敏反应病例的增加,而肾上腺素仿制药的推出预计将推动多年来的市场增长。然而,缺乏肾上腺素自动注射器及其低成本替代品可能会对未来几年的市场增长产生负面影响。

报告覆盖范围

预计肾上腺素市场在大流行后将出现大幅增长。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

利润丰厚的地区肾上腺素市场

市场洞察

肾上腺素在医疗保健中的不断增长的应用将推动肾上腺素市场增长

过敏反应是一种严重的、危及生命的过敏反应其症状包括皮肤发红和瘙痒、吞咽和呼吸困难、喘息、呼吸频率加快(呼吸急促)、心率加快(心动过速)和血压下降。它可能涉及人体的多个系统。过敏反应是由于接触被人体识别为非自身的过敏原(食物、昆虫叮咬或药物)而引起的。

全世界过敏反应的发生率正在增加;据 NICE 称,英国每年估计有 20 人因过敏反应死亡。此外,根据欧洲过敏和临床免疫学研究院的数据,每年约有 1.5 亿欧洲人患有慢性过敏性疾病。过敏反应是一种普遍的过敏反应。因此,过敏发生率的上升也导致过敏反应病例数量激增。全世界有大量人口患有各种过敏症。例如,根据美国过敏学院的过敏事实,哮喘和哮喘是一种常见的疾病。免疫学方面,每年有超过 5000 万美国人经历不同类型的过敏。此外,它还将过敏列为美国慢性病的第六大原因,也是儿童最常见的健康问题。 2015年,8.2%的成人和8.4%的儿童被诊断患有花粉热。据美国哮喘和过敏基金会称,过去几年,因食物过敏反应而去医院就诊的人数也有所增加。根据食物过敏研究与教育方面,约3200万美国人患有危及生命的食物过敏,每年有20万人因食物过敏而去急诊室就诊。过敏给许多国家的医疗保健系统带来了经济负担;例如,根据 Allergy Facts 的数据,美国每年处理过敏病例的费用超过 180 亿美元。过敏反应需要立即就医,如果治疗不当可能会致命。每年约有 90–100 美国人死于昆虫叮咬引起的过敏反应。

肾上腺素是过敏反应病例的一线治疗方法。根据研究,它通过血管收缩作用预防或减少上呼吸道粘膜水肿,即喉部水肿、低血压和休克。此外,它还具有重要的支气管扩张作用和强心力以及变时作用。因此,过敏反应发生率的增加正在推动市场的增长。

肾上腺素是治疗过敏反应最有效的方法;然而,各种研究表明,由于成本高、缺乏可用性、对使用程序的不了解和过敏发作等,该药物的利用不足。随着过去十年价格的急剧上涨,缺乏负担得起的替代品给患者带来了困难这种药。 EpiPen 是一种分配肾上腺素的注射装置,严重过敏的人一直依靠它来应对危及生命的过敏反应。单独的肾上腺素是一种仿制药,但 EpiPen 是一种药物-器械组合产品,这使得竞争对手很难复制并获得 FDA 批准。因此,这个领域的玩家数量有限。此外,肾上腺素的需求一直在上升,但产品供应有限。根据皮尤慈善信托基金会的数据,过去几年对肾上腺素自动注射器的需求有所增加,美国的 EpiPen 处方数量从 2011 年的约 250 万份增长到 2015 年的 350 万份。这一增长可归因于学校的需求量很大。

Mylan 长期以来一直是肾上腺素自动注射器市场的主导者。然而,2018 年,梯瓦制药 (Teva Pharmaceutical) 的肾上腺素自动注射器仿制药获得 FDA 批准。此次批准是美国处方最广泛的肾上腺素自动注射器的第一个通用版本。预计未来将促进获得成本更低、安全且有效的仿制药替代品。对于这种危及生命的情况,患者通常没有足够的药物选择;

基于产品类型的洞察

就产品类型而言,肾上腺素市场分为预充式注射器、自动注射器、安瓿和小瓶。自动注射器细分市场在 2019 年占据了最大的市场份额。预计在预测期内,自动注射器细分市场的复合年增长率也将达到 8.6%,为市场最高。

 

肾上腺素市场,按产品类型划分 – 2018年和2027年


基于应用的见解

根据应用,肾上腺素市场分为过敏反应、浅表出血、呼吸系统疾病、心脏骤停。过敏反应细分市场在 2019 年占据了最大的市场份额。预计在预测期内,过敏反应细分市场的复合年增长率也最高,达到 8.9%

分布基于渠道的洞察

就分销渠道而言,肾上腺素市场分为零售药店、医院药店、网上药店。零售药房细分市场在 2019 年占据最大市场份额。预计零售药房细分市场在预测期内的复合年增长率也最高,达到 8.9%。

< h3>战略洞察

肾上腺素市场参与者正在采取产品推出和扩张战略来满足全球不断变化的客户需求,这也使他们能够在全球范围内保持其品牌声誉。

  ;

肾上腺素市场——按产品类型

  • 预充式注射器
  • 自动注射器
  • 安瓿和小瓶

肾上腺素市场按应用分类

  • 过敏反应
  • 浅表出血
  • 呼吸系统疾病
  • 心脏骤停

肾上腺素市场——按分销渠道划分

  • 零售药房
  • 医院药房
  • 在线药房

肾上腺素市场 -按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
  • < /ul>

    公司简介

    • MYLAN NV
    • 雅培
    • ALK ABELLO
    • Amneal Pharma
    • Kaleo
    • LINCOLN MEDICAL LTD(BioProject)
    • Teva Pharmaceuticals Ltd
    • Adamis Pharmaceuticals Corporation (Novartis AG)
    • Emirade
    • Aurum Pharma
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is epinephrine?

Epinephrine is a medication used along with emergency medical treatment services for the allergic reactions caused by insect bites or stings, foods, drugs, and latex, among others. It works by relaxing the muscles in the airways and tightening the blood vessels. The injection is available as a prefilled automatic injection device that contains the solution and in vials to inject subcutaneously and others. The injection is generally injected as required at the first sign of a severe allergic reaction

What are the driving factors for the epinephrine market across the globe?

The key factor that are responsible for the growth of market include increasing anaphylaxis cases and introduction of generic version of epinephrine. However, lack of availability of epinephrine auto injectors and their low-cost alternatives is likely to have a negative impact on the growth of the market in the coming years.

What is the average cost of epinephrine?

The average cost of an epinephrine auto-injector is approximately US$130 - US$150. It is an emergency medicine used to treat severe allergic reactions. The drug is available in both innovative and generic brand. Thus, the cost of the drug may vary accordingly.

The List of Companies - Epinephrine Market

  1. MYLAN N.V
  2. Abbott
  3. ALK ABELLO
  4. Amneal Pharma
  5. Kaleo
  6. LINCOLN MEDICAL LTD (BioProject)
  7. Teva Pharmaceuticals Ltd
  8. Adamis Pharmaceuticals Corporation (Novartis AG)
  9. Emirade
  10. Aurum Pharma (Ethypharm Group Company).

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports